BHWM
UTHR icon

Bay Harbor Wealth Management’s United Therapeutics UTHR Stock Holding History

Bay Harbor Wealth Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.96K Buy
11
+1
+10% +$563 ﹤0.01% 385
2026
Q1 		$5.93K Buy
10
+4
+67% +$1.99K ﹤0.01% 310
2025
Q4 		$2.92K Buy
6
+2
+50% +$931 ﹤0.01% 395
2025
Q3 		$1.68K Buy
4
+1
+33% +$336 ﹤0.01% 402
2025
Q2 		$862 Buy
3
+1
+50% +$299 ﹤0.01% 492
2025
Q1 		$616 Buy
+2
New +$685 ﹤0.01% 390

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Bay Harbor Wealth Management's UTHR Position: Q2 2026 in Review

Bay Harbor Wealth Management increased its United Therapeutics (UTHR) stake by 10% in Q2 2026, buying an estimated $563 and bringing the position to 11 shares worth $5.96K. The position accounts for ﹤0.01% of the portfolio, ranked #385.

Bay Harbor Wealth Management first reported a position in UTHR in Q1 2025 and has held it in 6 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Bay Harbor Wealth Management held 11 shares of United Therapeutics worth $5.96K as of Q2 2026.
  • Bay Harbor Wealth Management bought 1 United Therapeutics share in Q2 2026, an estimated $563.
  • United Therapeutics made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #385 holding.
  • Bay Harbor Wealth Management first reported a position in United Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.